What are the most common neurological causes of muscle weakness?

Common neurological causes include neuromuscular‑junction disorders (myasthenia gravis), peripheral neuropathies (Guillain‑Barré syndrome, compressive neuropathies), upper‑motor‑neuron lesions (stroke, multiple sclerosis), and motor‑neuron diseases (ALS).

Can metabolic disorders cause reversible weakness?

Yes. Electrolyte abnormalities (hypokalemia, hypercalcemia), thyroid dysfunction, and vitamin deficiencies often produce weakness that improves markedly after correction of the underlying metabolic disturbance.

How do medication side effects mimic primary muscle disease?

Drugs such as statins, glucocorticoids, and certain antivirals can cause elevated creatine kinase, muscle pain, and proximal weakness that clinically resemble inflammatory myopathies or muscular dystrophies; a thorough medication review and temporal relationship help differentiate them.

When should a clinician suspect a neuromuscular‑junction disorder?

Suspect a junctional disorder when weakness fluctuates with activity, improves after rest, involves ocular or bulbar muscles early, and shows decremental response on repetitive nerve stimulation or positive acetylcholine‑receptor antibodies.

Causes of Muscle Weakness: Physical and Neurological Factors

Neuromuscular Junction Disorders

The neuromuscular junction (NMJ) is the specialized synapse where motor‑neuron terminals release acetylcholine to trigger muscle‑fiber contraction. Disruption of acetylcholine release, receptor binding, or signal termination reduces the safety factor of transmission, producing fatigable weakness that worsens with activity.

Myasthenia gravis is an autoimmune NMJ disorder in which antibodies target the acetylcholine‑receptor complex, lowering receptor density. Lambert‑Eaton myasthenic syndrome results from presynaptic voltage‑gated calcium‑channel antibodies that impair quantal release. Both conditions present with proximal, fluctuating weakness and often improve after brief rest.

Congenital myasthenic syndromes comprise a heterogeneous group of inherited defects affecting presynaptic, synaptic, or postsynaptic proteins (e.g., CHRNE, RAPSN, COLQ). Onset ranges from infancy to adulthood, and weakness patterns vary with the specific molecular lesion, but all share a primary NMJ transmission failure.

Diagram showing a motor neuron terminal, synaptic cleft, and muscle fiber with acetylcholine receptors

Peripheral Nerve Pathologies

Peripheral neuropathy denotes damage to axons or myelin sheaths of motor, sensory, or autonomic fibers. Axonal loss reduces the number of functional motor units, while demyelination slows conduction velocity; both mechanisms diminish the force a muscle can generate.

Acute inflammatory demyelinating polyradiculoneuropathy (Guillain‑Barré syndrome) produces rapidly ascending weakness due to immune‑mediated myelin stripping. Chronic inflammatory demyelinating polyneuropathy (CIDP) follows a relapsing or progressive course with similar demyelinating pathology but a longer time scale.

Focal nerve compression syndromes — such as carpal‑tunnel syndrome (median nerve at the wrist), ulnar neuropathy at the elbow, and lumbar radiculopathy from disc herniation — cause weakness limited to the distribution of the affected nerve. Electrodiagnostic studies localize the lesion and differentiate compression from systemic neuropathy.

Carpal‑tunnel syndrome – median nerve compression at the wrist
Ulnar neuropathy – compression at the cubital tunnel
Lumbar radiculopathy – nerve‑root compression from disc herniation
Peroneal neuropathy – compression at the fibular head

Primary Muscle Diseases

Muscular dystrophies are inherited disorders caused by mutations in genes encoding structural proteins (e.g., dystrophin in Duchenne/Becker, sarcoglycans in limb‑girdle types). Loss of membrane integrity leads to progressive fiber necrosis, replacement by fat and fibrosis, and symmetric proximal weakness.

Inflammatory myopathies include polymyositis, dermatomyositis, and inclusion‑body myositis. Autoimmune attack on muscle fibers (or, in inclusion‑body myositis, combined degenerative and inflammatory features) produces subacute proximal weakness, often with elevated creatine kinase and characteristic muscle‑biopsy findings.

Metabolic myopathies arise from defects in energy production pathways. Mitochondrial disorders impair oxidative phosphorylation, while glycogen‑storage diseases (e.g., McArdle disease) block glycolytic flux. Episodes of exertional weakness, cramps, or rhabdomyolysis are typical, and diagnosis often requires genetic or biochemical testing.

Microscopic view of skeletal muscle showing fiber size variation, central nuclei, and fibrous replacement

Central Nervous System Lesions

Upper motor neuron (UMN) lesions interrupt corticospinal tract signals before they reach anterior‑horn cells. The resulting weakness is characterized by spasticity, hyperreflexia, and a pyramidal distribution (e.g., hemiparesis after stroke). Muscle bulk is usually preserved early because lower motor neurons remain intact.

Stroke, traumatic spinal‑cord injury, and demyelinating diseases such as multiple sclerosis are common UMN causes. In multiple sclerosis, plaques in the cerebral hemispheres, brainstem, or spinal cord produce relapsing‑remitting or progressive weakness depending on lesion location and burden.

Neurodegenerative motor‑neuron diseases — amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS) — involve both upper and lower motor neurons (ALS) or predominantly UMNs (PLS). ALS leads to combined spastic and flaccid weakness with atrophy, while PLS produces pure spastic paresis that progresses over years.

Systemic Metabolic and Endocrine Factors

Electrolyte disturbances alter membrane excitability. Hypokalemia reduces resting membrane potential, impairing action‑potential generation and causing flaccid weakness; severe hypercalcemia depresses neuromuscular transmission. Rapid correction can precipitate arrhythmias, so monitored repletion is essential.

Endocrine disorders frequently produce proximal myopathy. Hypothyroidism yields slow‑relaxing weakness with elevated creatine kinase; hyperthyroidism may cause thyrotoxic periodic paralysis in susceptible individuals. Cushing’s syndrome and chronic glucocorticoid excess produce a characteristic steroid myopathy with type‑II fiber atrophy. Diabetes mellitus contributes via microvascular nerve ischemia and metabolic derangements.

Nutritional deficiencies also weaken muscle. Vitamin D deficiency causes osteomalacia‑related proximal weakness; vitamin B12 deficiency leads to subacute combined degeneration affecting dorsal columns and peripheral nerves. Protein‑energy malnutrition reduces muscle mass and contractile protein synthesis, compounding weakness from other causes.

Category	Typical Mechanism	Key Laboratory Clue
Electrolyte imbalance	Altered membrane excitability	Serum K⁺, Ca²⁺, Mg²⁺
Thyroid dysfunction	Altered protein turnover & ion channels	TSH, free T4, T3
Glucocorticoid excess	Type‑II fiber atrophy, proteolysis	Cortisol, dexamethasone suppression
Vitamin D deficiency	Impaired calcium handling, osteomalacia	25‑OH vitamin D
Vitamin B12 deficiency	Demyelination of peripheral nerves & spinal cord	Serum B12, methylmalonic acid

Drug‑Induced and Toxic Myopathies

Statin‑associated muscle symptoms range from asymptomatic CK elevation to necrotizing autoimmune myopathy. The mechanism involves impaired cholesterol synthesis in muscle membranes and, in rare cases, an immune response against HMG‑CoA reductase. Risk rises with high‑dose therapy, drug interactions, and hypothyroidism.

Corticosteroid myopathy develops after weeks to months of high‑dose glucocorticoids, producing selective type‑II fiber atrophy without inflammation. Colchicine, chloroquine, and certain antiretrovirals (e.g., zidovudine) cause vacuolar myopathy with mitochondrial dysfunction. Discontinuation often reverses weakness, though recovery may be incomplete.

Chronic alcohol exposure leads to a painless proximal myopathy with type‑II fiber atrophy and mitochondrial abnormalities. Heavy‑metal toxicity (lead, arsenic) and organophosphate poisoning impair neuromuscular transmission and cause secondary axonal degeneration. Occupational history and toxicology screening guide diagnosis.